Elevated circulating soluble thrombomodulin activity, tissue factor activity and circulating procoagulant phospholipids: New and useful markers for pre-eclampsia?
Authors:
- Patrick Van DredenPDPatrick Van Dreden
- 1 September 2009
- journal article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 146 (1) , 46-49
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Haemostasis and pregnancyThrombosis and Haemostasis, 2006
- Latest Advances in Understanding PreeclampsiaScience, 2005
- Soluble thrombomodulin activity and soluble thrombomodulin antigen in plasmaJournal of Thrombosis and Haemostasis, 2005
- The thrombomodulin–protein C system is essential for the maintenance of pregnancyNature Medicine, 2003
- Disruption of the Endothelial Cell Protein C Receptor Gene in Mice Causes Placental Thrombosis and Early Embryonic LethalityJournal of Biological Chemistry, 2002
- Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolismEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2001
- Mouse embryogenesis requires the tissue factor extracellular domain but not the cytoplasmic domainJournal of Clinical Investigation, 2000
- Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosisBlood, 2000
- Plasma Procarboxypeptidase U in Men with Symptomatic Coronary Artery DiseaseThrombosis and Haemostasis, 2000
- Identification of functional endothelial protein C receptor in human plasma.Journal of Clinical Investigation, 1997